Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
about
Epigenetic gene regulation in the bacterial worldDetailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection.Identification of exopolysaccharide-deficient mutants of Mycoplasma pulmonis.The severity of chorioamnionitis in pregnant sheep is associated with in vivo variation of the surface-exposed multiple-banded antigen/gene of Ureaplasma parvum.Mycoplasma agalactiae MAG_5040 is a Mg2+-dependent, sugar-nonspecific SNase recognised by the host humoral response during natural infection.Ureaplasma parvum serovar 3 multiple banded antigen size variation after chronic intra-amniotic infection/colonization.A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidinMAP1272c encodes an NlpC/P60 protein, an antigen detected in cattle with Johne's disease.Phase-locked mutants of Mycoplasma agalactiae: defining the molecular switch of high-frequency Vpma antigenic variationMycoplasma polysaccharide protects against complementMolecular mechanisms of pathogenicity of Mycoplasma mycoides subsp. mycoides SC.Occurrence, plasticity, and evolution of the vpma gene family, a genetic system devoted to high-frequency surface variation in Mycoplasma agalactiae.Mycoplasma biofilms ex vivo and in vivo.Phase and antigenic variation in mycoplasmas.Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cellsThe Vsa shield of Mycoplasma pulmonis is antiphagocytic.Mycoplasma lipoproteins are major determinants of neutrophil extracellular trap formation.Phenotypic characterization of Mycoplasma synoviae induced changes in the metabolic and sensitivity profile of in vitro infected chicken chondrocytes.Genome of Mycoplasma arthritidis.Evidence for type III restriction and modification systems in Mycoplasma pulmonis.Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis.EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host
P2860
Q24669987-4C4C9C32-A737-4AE3-A7C6-459D83CB2868Q33408773-06369152-ACC0-4032-AE63-19B0F8937323Q33443418-E61F7E0B-9EB6-4836-9AFB-2C5544332CCAQ34076712-BD15901B-8E9E-4786-91C8-C85AE81C23E3Q34612426-B7511147-E455-4DA3-BCC7-EA8351B84FF9Q34701992-7B985BB2-8FCF-44E7-A2E0-50F29A096D52Q35759336-90DD94EE-9F54-4814-A602-E41F5E208B79Q35949774-95A6BABD-3707-4937-A708-E7460C329F34Q36086280-6EE7D79F-9FD8-4E35-BDCA-16963AC266E6Q36499663-A2FD4A65-D2BE-4F55-A57C-2945C1C8A62CQ36524038-69E2E265-A80A-4DB0-B8DB-9171D7CAAA5AQ36677859-5DC25C21-3213-4820-8CA5-6502F7A293E3Q37232752-E9843685-C4FE-4867-9DC2-3F2CFDBCC75EQ37244271-33527F8A-D3CF-4F2D-A823-12F73E6FEB15Q37772891-292827AB-6845-4908-AD54-DACDDEF83C4DQ39377238-B2365CA3-3C7F-4018-983B-C82E75E2C2CEQ39443106-5036FE82-C6D4-4700-9016-EABE84D7761CQ40679560-A1AE99AA-98FA-489E-BBC6-4D5EC8883255Q41730849-3F62D715-A5CA-4390-8A05-2B41C8BEB53BQ41836754-737AE120-42C2-4A8B-9329-2A0AB223367DQ42002472-91901FAE-099D-493B-8943-64BB250CCB28Q42373327-AAFA8FAD-4280-4724-B221-71D1171DD70EQ42523318-4892E87D-DDBE-41DF-A526-0E0F106712E7Q42706610-F08AD45A-8E61-4F91-9F14-107C42320013
P2860
Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
@ast
Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
@en
type
label
Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
@ast
Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
@en
prefLabel
Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
@ast
Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
@en
P2093
P2860
P1476
Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
@en
P2093
Amy M Denison
Brenda Clapper
Kevin Dybvig
P2860
P304
P356
10.1128/IAI.73.4.2033-2039.2005
P407
P577
2005-04-01T00:00:00Z